fenofibrate has been researched along with 4-hydroxy-2-nonenal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alary, J; Costet, P; Debrauwer, L; Dolo, L; Guéraud, F; Paris, A; Pineau, T | 1 |
| Besson, VC; Chen, XR; Garcia, Y; Marchand-Leroux, C; Palmier, B; Plotkine, M | 1 |
2 other study(ies) available for fenofibrate and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
In vivo involvement of cytochrome P450 4A family in the oxidative metabolism of the lipid peroxidation product trans-4-hydroxy-2-nonenal, using PPARalpha-deficient mice.
Topics: Aldehydes; Animals; Chromatography, High Pressure Liquid; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Female; Fenofibrate; Hydroxylation; Hypolipidemic Agents; Lipid Peroxidation; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbodies; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors | 1999 |
Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury.
Topics: Aldehydes; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Brain Injuries; Cyclooxygenase 2; Encephalitis; Fenofibrate; Glutathione; Male; Matrix Metalloproteinase 9; Nitric Oxide Synthase Type II; Oxidative Stress; PPAR alpha; Rats; Rats, Sprague-Dawley; Recovery of Function; Treatment Outcome; Tyrosine | 2007 |